Tumor growth within the GCSFR/ RAG2/ mice (Fig. 3A). For that reason, these
Tumor development in the GCSFR/ RAG2/ mice (Fig. 3A). Hence, these data recommend that the capacity of antiVEGF to lessen tumor development is directly correlated with decreased CD11bLy6G neutrophil mobilization…